Try our Advanced Search for more refined results
Health - April, 2007
128 articles
- Judge Orders Synergetics To Reply To Rival's Claim
- FDA Rejects Merck's Latest COX-2 Drug
- Title VII Suit Against Kidney Service To Proceed
- Katrina Patients Class Action Stays In State Court
- Controlling Health Care Costs With Wellness Programs
- Tax Traps for Health System Parent Entities
- Experts Praise Patent Reform, Suggest Changes
- Blue Cross Settles Doctor Fraud Claims For $128M
- EU Court Tentatively OK's Branded Drug Resale
- U.S. Joins Medicare Fraud Whistleblower Case
- Royal Philips Settles Defibrillator Dispute
- Brazil Threatens To Break Merck's Efavirenz Patent
- Dental Co. Sued For Alleged Monopolistic Practices
- Lawyers Win More For Plaintiffs In Glaxo Settlement
- EU Parliament OK's Rules For Gene Therapy Industry
- Greenberg, Attorney Dispute Malpractice Suit
- Hospital Sued For Alleged X-Ray Conspiracy
- Teva v. Novartis: Post-MedImmune Declaratory Judgment
- Court Dismisses Suit Over Talking Defibrillator
- Becton Dickinson Licensing Deals Under Scrutiny
- Abbott Unit Defeats Inequitable Conduct Claims
- Claim Constructions Adopted In Medtronic v. Cordis
- Supreme Court Ditches Medicaid Kickback Case
- Kentucky River Case Causes Workforce Scrutiny
- Complaint Granted In Novartis Bone Drug Case
- Pepper Hamilton Welcomes Two Health Specialists
- Cardinal Health Tags $600M For Securities Settlement
- Mayer Brown Advises AstraZeneca On Acquisition
- Wyeth Sues To Protect Its Best-Selling Drug
- Federal Circuit Affirms Ruling On Prilosec Process
- Novartis Dismisses Some Exelon Patent Claims
- Scrushy Keeps Home In $81M SEC Settlement
- Judge's Ruling Will Suspend Texas Vioxx Suits
- Amgen Exec's Spouse Settles Fraud Charge
- Declaratory Judgment Sought Over Allergy Patent
- Greenberg Traurig Hit With Malpractice Suit
- $100M Workers Comp Scam Yields 5 Indictments
- Three Rivers Sues Rival Over Hep C Treatment
- Probation Not Enough For Ex-HealthSouth Official
- FDA Blocks New Generic Versions Of Pfizer's Norvasc
- Court Nixes Retaliation Claim Against St. Luke's
- Scrushy Makes Bid For New Trial
- Loeb & Loeb Picks Up Patent Litigator
- Judge Refuses To Toss Intuitive Suit Against Caltech
- Teva Fights For Biaxin Marketing Rights
- Hospitals, Doctors Join Action Against Blue Cross
- Cutera Beamed By Securities Suit
- MedPointe Sues Apotex Over Allergy Treatments
- FDA Revitalization Bill Progresses In Senate
- Senate Blocks Medicare Drug Bill
- Roche's Bid For Stay Denied In HIV Technology Case
- DOJ Official Says Reverse Payments Not Illegal
- Shareholders Sue Amgen Over Anemia Drugs
- Authorized Generics Benefit Consumers: Report
- PDL Biopharma Sues to Protect Cardene I.V.
- ICU To Pay Attorneys' Fees To Alaris In Patent Case
- FDA Seizes Products From Device Maker
- Warner Chilcott Settles Second Ovcon Case
- Texas AG Sues CVS For Dumping Customer Records
- After Divestiture, FTC To Allow Drug Acquistion
- J&J Unit, NYU Sue Abbott Over Humira
- Novozymes Wins $15M From Danish Rival
- Cell Therapeutics Pays Up In Off-Label Marketing Case
- Maryland Backs Down In "Wal-Mart Law" Fight
- High Court Hears Home Care Worker's Wage Case
- Court Upholds Ex-HealthSouth VP's Conviction
- Suit Alleges Hospital Monopoly Over Imaging Services
- Ariad Sues Amgen, Wyeth Over Enbrel
- Biotech Cos. Settle Trade Secrets Spat
- Court Rules Against J&J Unit In Artificial Disc Case
- Injunction Against Stryker Vacated
- Medicare Drug Bill Passes Senate Committee
- Governors Send Support For Biologic Bill
- Judge Tosses Vioxx Securities Suit
- Panel Confirms Shoddy Conditions At Walter Reed
- Health Insurer Sued Under RICO
- Antitrust Allegations Add Fire To Catheter Dispute
- Fed. Circ. Upholds Ruling Against Generic Acular
- Appeals Court Upholds Injunction On Generic Topamax
- Emerging Weapons Against Generics Competition
- Teva Targets 13th Drug Maker In Zoloft Patent Battle
- Abbott Backs Down In Kaletra Pricing Fight
- Judge Dismisses Fosamax Case
- Despite Definite Veto, Senate Pushes Stem Cell Bill
- Authorized Generics In Spotlight At Senate Hearing
- Eye Surgery Rivals Settle Patent Claims For $6.5M
- AstraZeneca Hits Sandoz With Seroquel Patent Suit
- Jury Awards Doctor $6.3M
- Bayer Sues Teva Over Patents For Avelox
- Ex-Endocare Execs On The Hook For Fraud Charges
- Merck Sues To Block Generic Singulair
- Juries Side With Doctors: Study
- Judge Orders More Monitoring Of Scrushy
- India Begs Novartis To Drop Patent Challenge
- Miracle Drug Or Overdose?
- USPTO To Reissue Seasonale Patent
- J&J Fires Back At Sales Rep In Overtime Pay Suit
- J&J Wins Patent Fight Over Drug Stent
- VaxGen Receives $11M Consolation Prize
- Insulation Cos. Plead Guilty To Bid-Rigging
- Negotiating Medicare Fees Would Save $30B: Study
- Outstanding Women: Patricia Meador
- Judge Certifies New Claim In Abbott Class Action
- Johnson & Johnson Pays $11M To End Antitrust Suit
- Invalid Patent Correction Leads To Reversal
- Pfizer's U.K. Drug Distribution Deal Draws Scutiny
- Outstanding Women: Linda Friedman
- Hospitals Get Go-Ahead To Sue Transcribers For Fraud
- St. Vincent Wants Caritas To Pay Up
- Judge Tosses Case For Failure To Prove Scienter
- California Sued Over Law For HIV Patients
- Shareholders Target Lilly Over Zyprexa
- Drug Companies Spend Record On Lobbying
- PTO Rejects Claims On Stem Cell Patents
- Senate Eyes Penn. Health Insurers' Merger
- Circuit Court Rules On "Fiduciary Exception"
- Bristol-Myers Subpoenaed Over Plavix Deal
- Palomar, Alma End Light-Based Hair Removal Suit
- Outstanding Women: Elisabeth Belmont
- Purdue, Impax Settle Oxycontin Litigation
- N.Y. Health Provider Labels Becton Anti-Competitive
- Options Backdating Catches Up To Biomet
- Outstanding Women: Elizabeth Carder-Thompson
- Physician Sentenced For Securities, Medicare Fraud
- High Court Refuses Ranbaxy's Lipitor Appeal
- Pfizer Pays $34.7M To Settle Genotropin Charges
- Medtronic Wins Appeal In Spinal Screw Patent Suit
- Tenet To Pay $10M To Settle With SEC